Pharmacy World & Science

, Volume 30, Issue 5, pp 556–562 | Cite as

The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul

  • Hale Zerrin TokluEmail author
  • Meral Keyer Uysal
Research Article


Objective We investigated the knowledge and attitudes of community pharmacists towards pharmacovigilance and adverse drug reactions (ADRs) in Kadıköy district of Istanbul (Turkey). Setting The community pharmacies in Kadikoy. Kadikoy is one of the biggest districts of Istanbul and has the largest number of pharmacies. Kadikoy district was divided into two regions, the central and the peripheral. Method Between December 2005 and June 2006 we conducted a survey about the knowledge and attitude of community pharmacists (n = 219) using a face-to-face questionnaire. The questionnaire consisted of questions about the sociodemographic characteristics of the pharmacists, their knowledge of pharmacovigilance and their attitudes towards ADR reporting. Main outcomes measured The knowledge of pharmacovigilance practice, ADR reporting compliance rates, reasons for not reporting ADR and perceptions of the Turkish community pharmacists on pharmacovigilance practice were evaluated. Results Although all 411 pharmacies in the Kadikoy district were visited, only 53% of the community pharmacists (n = 219) consented to participate in the study. Of those that did respond, only 17.2% of the pharmacists had any knowledge about ‘pharmacovigilance’. Sixty-five percent of the pharmacists stated that patients reported an ADR to them during the previous 12 months, and 21% of pharmacists reported to the concerned organizations. Our survey showed that only 7% actually reported an ADR to the national pharmacovigilance center. On the other hand, 89% of the pharmacists believed that the role of the pharmacist in ADR reporting was essential. Conclusion The results show that Turkish community pharmacists have poor knowledge about pharmacovigilance. There is an urgent need for educational programs to train them about pharmacovigilance and ADR reporting.


Adverse drug reaction reporting Attitude Community pharmacist Community pharmacy Knowledge Pharmacovigilance Turkey 



The authors are grateful to the Ecehan Balta and Caner Eryol from the Turkish Pharmacists Association and to Cigdem Engin, the responsible pharmacist of Kadıköy Local Board of Health for their valuable contributions. They also thank to Aaron Weitzman from the University of Maryland, College Park for assistance in the final preparation of the article.



Conflicts of interest



  1. 1.
    Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004;18(3):275–80.PubMedCrossRefGoogle Scholar
  2. 2.
    WHO publications. The importance of pharmacovigilance: safety monitoring of medicinal products. WHO Collaborating Centre for International Drug Monitoring, Geneva, Switzerland; 2002. ISBN 92-4-159015-7.Google Scholar
  3. 3.
    Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. Pharmacovigilance in developing countries. BMJ. 2007;335(7618):462.PubMedCrossRefGoogle Scholar
  4. 4.
    WHO. Pharmacovigilance: ensuring the safe use of medicines. WHO Policy Perspectives on Medicines, Geneva, Switzerland; 2004. Accessed Oct 26th, 2007.
  5. 5.
    FIP (International Pharmaceutical Federation) Statement of Policy: the role of the pharmacist in pharmacovigilance, Brazil; 2006. Accessed Oct 26th, 2007.
  6. 6.
    Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400–3.PubMedGoogle Scholar
  7. 7.
    Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29(4):365–9.PubMedGoogle Scholar
  8. 8.
    Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Safety. 2000;23(2):165–72.PubMedCrossRefGoogle Scholar
  9. 9.
    Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case–control study in Portugal. Drug Safety. 2006;29(4):331–40.PubMedCrossRefGoogle Scholar
  10. 10.
    Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists’ attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Safety. 2007;16(4):429–34.CrossRefGoogle Scholar
  11. 11.
    Beşeri Tıbbi Ürünlerin Güvenliğinin İzlenmesi ve Değerlendirilmesi Hakkında Yönetmelik (22 Mart 2005 tarihli ve 25763 sayılı Resmi Gazete, yürürlüğe giriş tarihi: 30/06/2005) [Guide for the monitorization and evaluation of the medicinal products. Published in the official gazette in 30th March 2005 to become valid by 30th June 2005]. Accessed Oct 26th, 2007.
  12. 12.
    Ozcelikay G, Tekiner H. Turkiye’de Eczacılık Insan Gucunun Degerlendirilmesi ve Eczane Dagilimlari. [The distribution of the pharmacies in Turkey and evaluation of Pharmacist resources in Turkey]. Turkish Pharmacist Association Publications, Ankara, Turkey; 2007. ISBN 978-975-01139-4-9.Google Scholar
  13. 13.
    Onder Ozhan. Eczacı Profili: 1998–2007 Son On Yıla Bir Bakış [The profile of the community pharmacists: 1998–2007 An overview of the last ten years]. Turkish Pharmacist Association Publications, Ankara, Turkey; Research Series 2007.Google Scholar
  14. 14.
    Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Safety. 2006;29(5):385–96.PubMedCrossRefGoogle Scholar
  15. 15.
    Laing R. Role of dispensers in promoting rational drug use. WHO/INRUD Trainer’s Guide; 1997. Accessed Oct 26th, 2007.
  16. 16.
    Gedde-Dahl A, Harg P, Stenberg-Nilsen H, Buajordet M, Granas AG, Horn AM. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiol Drug Safety. 2007;16(9):999–1005.CrossRefGoogle Scholar
  17. 17.
    van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Safety. 2004;13(7):457–64.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  1. 1.Department of PharmacologyMarmara University School of PharmacyIstanbulTurkey

Personalised recommendations